1. Home
  2. CERO vs BAOS Comparison

CERO vs BAOS Comparison

Compare CERO & BAOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • BAOS
  • Stock Information
  • Founded
  • CERO 2017
  • BAOS 2018
  • Country
  • CERO United States
  • BAOS China
  • Employees
  • CERO 8
  • BAOS N/A
  • Industry
  • CERO
  • BAOS Business Services
  • Sector
  • CERO
  • BAOS Consumer Discretionary
  • Exchange
  • CERO Nasdaq
  • BAOS Nasdaq
  • Market Cap
  • CERO 3.7M
  • BAOS 3.4M
  • IPO Year
  • CERO N/A
  • BAOS 2021
  • Fundamental
  • Price
  • CERO $0.45
  • BAOS $3.76
  • Analyst Decision
  • CERO Buy
  • BAOS
  • Analyst Count
  • CERO 2
  • BAOS 0
  • Target Price
  • CERO $3.00
  • BAOS N/A
  • AVG Volume (30 Days)
  • CERO 993.4K
  • BAOS 4.1M
  • Earning Date
  • CERO 05-15-2025
  • BAOS 06-17-2025
  • Dividend Yield
  • CERO N/A
  • BAOS N/A
  • EPS Growth
  • CERO N/A
  • BAOS N/A
  • EPS
  • CERO N/A
  • BAOS N/A
  • Revenue
  • CERO N/A
  • BAOS $624,087.00
  • Revenue This Year
  • CERO N/A
  • BAOS N/A
  • Revenue Next Year
  • CERO N/A
  • BAOS N/A
  • P/E Ratio
  • CERO N/A
  • BAOS N/A
  • Revenue Growth
  • CERO N/A
  • BAOS N/A
  • 52 Week Low
  • CERO $0.40
  • BAOS $1.44
  • 52 Week High
  • CERO $102.00
  • BAOS $13.66
  • Technical
  • Relative Strength Index (RSI)
  • CERO 35.19
  • BAOS 74.48
  • Support Level
  • CERO $0.42
  • BAOS $2.27
  • Resistance Level
  • CERO $0.50
  • BAOS $4.39
  • Average True Range (ATR)
  • CERO 0.05
  • BAOS 0.33
  • MACD
  • CERO 0.00
  • BAOS 0.16
  • Stochastic Oscillator
  • CERO 24.77
  • BAOS 71.23

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About BAOS Baosheng Media Group Holdings

Baosheng Media Group Holdings Ltd operates as a V-log streaming marketing service provider. The firm offers comprehensive marketing solutions. Its services are Internet effect marketing, V-log or short video streaming marketing including content production and operation, e-commerce marketing, original big data platform system service, and AI technology. It provides one-stop and full-link deep customized marketing solutions for partners. Baosheng Group is also a core agency of domestic Internet companies such as Tencent, Alibaba, Bytedance, and Kuaishou, with performing channel marketing services, technologies, and applications.

Share on Social Networks: